Quadrant Capital Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,638
| Closed | -$39.6K | – | 2590 |
|
|
2025
Q1 | $39.6K | Buy |
1,638
+296
| +22% | +$7.15K | ﹤0.01% | 1793 |
|
|
2024
Q4 | $54K | Buy |
1,342
+248
| +23% | +$9.98K | ﹤0.01% | 1372 |
|
|
2024
Q3 | $69.3K | Sell |
1,094
-5
| -0.5% | -$317 | ﹤0.01% | 1278 |
|
|
2024
Q2 | $58.3K | Sell |
1,099
-7
| -0.6% | -$371 | ﹤0.01% | 1327 |
|
|
2024
Q1 | $90.7K | Sell |
1,106
-286
| -21% | -$23.5K | 0.01% | 1065 |
|
|
2023
Q4 | $25.9K | Hold |
1,392
| – | – | ﹤0.01% | 1698 |
|
|
2023
Q3 | $15.4K | Hold |
1,392
| – | – | ﹤0.01% | 1815 |
|
|
2023
Q2 | $22.6K | Sell |
1,392
-883
| -39% | -$14.3K | ﹤0.01% | 1658 |
|
|
2023
Q1 | $37.9K | Sell |
2,275
-294
| -11% | -$4.9K | ﹤0.01% | 1387 |
|
|
2022
Q4 | $24.1K | Sell |
2,569
-89
| -3% | -$837 | ﹤0.01% | 1570 |
|
|
2022
Q3 | $7K | Sell |
2,658
-389
| -13% | -$1.02K | ﹤0.01% | 2042 |
|
|
2022
Q2 | $9K | Buy |
3,047
+2,745
| +909% | +$8.11K | ﹤0.01% | 1744 |
|
|
2022
Q1 | $1K | Buy |
302
+277
| +1,108% | +$917 | ﹤0.01% | 2407 |
|
|
2021
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 2708 |
|
|
2021
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 2661 |
|
|
2021
Q2 | $0 | Buy |
+25
| New | – | ﹤0.01% | 2576 |
|